also on other fortune lists

company facts

f500 stats

Fortune 500




As go drug sales (and prices), so go the fortunes of drug distributors like Pennsylvania-based AmerisourceBergen, which acts as a middleman, delivering medicines from manufacturers to pharmacies and hospitals. AmerisourceBergen’s revenues climbed 9.7% in 2018 thanks to overall market growth and brisk sales of expensive cancer drugs. The company’s acquisition of wholesaler H.D. Smith—completed in January of 2018—and the performance of its joint venture with Profarma in Brazil also boosted revenues, as did AmerisourceBergen’s veterinary medicine business. The company is facing issues involving its drug compounding subsidiary PharMEDium and, like its competitors, AmerisourceBergen is under scrutiny for its alleged role in the nation’s opioid crisis.

Looking for leads, investment insights, or competitive intelligence?


Steven H. Collis

CEO Title

Chairman, President & Chief Executive Officer


Health Care


Wholesalers: Health Care

HQ Location

Chesterbrook, Pa.

Years on Fortune 500 List




Figures are for fiscal year ended Sept. 30, 2018.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$167,939.69.7%
Profits ($M)$1,658.4355.0%
Assets ($M)$37,669.8
Total Stockholder Equity ($M)$2,932.8
Profit Ratios
Profit as % of Revenues1.0%
Profits as % of Assets4.4%
Profits as % of Stockholder Equity56.5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)7.53
EPS % Change (from 2017)359.1%
EPS % Change (5 year annual rate)32.6%
EPS % Change (10 year annual rate)25.6%
Total Return
Total Return to Investors (2018)-17.6%
Total Return to Investors (5 year, annualized)2.7%
Total Return to Investors (10 year, annualized)17.0%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AmerisourceBergen

AmerisourceBergen CEO Says Getting Employees to Think Big is Key to Success

Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500

Read More →
Amerisource CEO Doubts Amazon will be a "Significant Force" in Drug Industry

Steve Collis predicts new era of where drug prices are going to come down.

Read More →
Amazon, Berkshire Hathaway and J.P. Morgan Are Forming a Non-Profit Health Care Venture

Sparking a selloff in the shares of a host of health care-related companies.

Read More →